“Could endemic covid leave millions disabled with long-haul symptoms every year, creating a growing public health crisis?”
“Maybe this is a chance for us,” said Krumholz, who is working with colleagues to design rigorous, broad-based studies. @hmkyale
1/
Among his fellow researchers is Akiko Iwasaki, a Yale immunologist and principal investigator at the Howard Hughes Medical Institute, who lists five hypotheses that she believes could explain the biological underpinning of long covid.” 2/ @VirusesImmunity@YaleMed
“They are equal partners,” Iwasaki said of patients, including the advocacy group @SurvivorCorps, which has 180,000 members and worked with the Yale researchers to design studies and recruit participants.
en short shrift for a long time.” #Lyme#MECFS@danaparish@Yale
4/
“Survivor Corps founder Diana Zicklin Berrent, who had covid early in the pandemic, recalled how people with ME/CFS and similar conditions initially looked with envy at the attention garnered by covid long-haulers.”
/5
“It was, ‘Wait a second, we’ve been suffering all these years and nobody pays attention to us. These guys come along, and everybody pays attention,’” recalled Berrent. She soon realized it made sense to join forces.
/6
“I think it’s an obligation of the long-covid world to pull these other communities along with us in research,” she said. “They have gotten short shrift for a long time.”
/7
“The NIH initiative, known as RECOVER, announced its first major awards in June, to support infrastructure and the development of core resources.”
/8 @NIH@nyulangone
“While patient advocacy groups were involved in the development of protocols, some fear that the research will be cumbersome and take on a life of its own in the rarefied world of academic medicine.”
/9
“The grass-roots groups have already proved their value in citizen-scientist collaborations, according to Survivor Corps’ Berrent, who is now free of symptoms.”
/9
“I really feel a kinship with these other groups,” Berrent said. “We are in touch with all of these people because it is so important that we don’t leave people behind, that we end up with a net benefit for humanity.” #chronicillness
/end
• • •
Missing some Tweet in this thread? You can try to
force a refresh
“If a deceased donor may have had long Covid and tested negative for Covid, however, the organs would be taken, Dr. Kumar said: “If we start turning down everyone who has had Covid in the past, we’d be turning down a lot of organs.”
“Before she died, Ms. Ferrer chronicled her ordeal in meticulous notes left on her phone: “Covid toes” that made her feet so sore she could not walk. A tremor that made her body shake violently. Pain in every limb. Relentless insomnia and despair.”
The New Yorker’s article on Long covid, in which I was a central subject, was a profound affront to everyone suffering the long-term sequelae of even mild and asymptomatic cases of covid-19 (“The Damage Done,” September 27th).
1/
The piece included no interviews with doctors or scientists directly investigating Long covid, and no interviews with patients battling the disease.
2/
The @NewYorker’s first article on #LongTermCovid, published in the September 27, 2021 issue, was a profound affront to everyone suffering the very real long-term sequalae of even mild and asymptomatic cases of #Covid_19.
2/
It is riddled with errors and was reported under false pretenses. @DhruvKhullar pitched this story to me as a personal profile – documenting how I started the world’s largest Covid movement, @Survivor_Corps.
3/
Thought it was hard to find monoclonal antibodies before? Well, it's about to get harder.
@HHSGov just announced that rather than take orders from hospitals they will allocate to states based on hospitalization rates and have the states distribute them.
1/
This system will reward the states with the lowest vaccination rates and harm those with the highest.
Ex: NY has high vax rate and low hospitalization rate. NY will receive 4000 doses weekly. How will they be given out?
2/
If they are distributed to each participating hospital no one will provide the therapeutic. It is too costly to set up an infusion center if you only have 10 doses to give out weekly.
PSA: if you weren’t able to get tested for Covid and / or didn’t have a detectable antibody response you are STILL eligible to be treated at a Post-Covid Care Center.
“At this time, no laboratory test can definitively distinguish post-COVID conditions from other etiologies, in part due to the heterogeneity of post-COVID conditions.”